IPO Traffic: Week Ending Sept. 11, 2015

  Lead Manager/ # of Price Range   Dollar SCOOP
New Filings (Proposed Symbol) Joint-Lead Managers Shares Low High Volume Ratings
American Renal Associates Holdings (ARA) BofA Merrill Lynch/ Barclays/ Goldman Sachs/ Wells Fargo Securities/ SunTrust Robinson Humphrey Leerink Partners $100.00 n.a.
AnaptysBio (ANAB) BMO Capital Markets/ Stifel $86.25 n.a.
At Home Group (HOME) BofA Merrill Lynch/ Goldman Sachs $100.00 n.a.
Capitol Acquisition Corp. III (TBA) Citigroup 35.00 $10.00 $10.00 $350.00 n.a.
IC Power Pte. Ltd. (ICP) BofA Merrill Lynch/ Credit Suisse $100.00 n.a.
McGraw-Hill Education (TBA) TBA $100.00 n.a.
NovoCure (NVCR) J.P. Morgan/ Deutsche Bank Securities/ Evercore ISI/ Wells Fargo Securities $300.00 n.a.
PharMEDium Healthcare Holdings (PMHC) Credit Suisse/ J.P. Morgan/ Morgan Stanley/ BofA Merrill Lynch/ Goldman Sachs $100.00 n.a.
PointClickCare (PCLK) J.P. Morgan Goldman Sachs/ RBC Capital Markets $100.00 n.a.
PSAV (PSAV) Goldman Sachs/ Morgan Stanley $100.00 n.a.
Sancilio Pharmaceuticals (SPCI) UBS Investment Bank/ Piper Jaffray $86.25 n.a.
n.a. (not available)
TBA (to be announced)
u (unit offering)
Energy & Exploration Partners (ENXP) Citigroup/ Credit Suisse/ RBC Capital Markets/ BofA Merrill Lynch/ UBS Investment Bank $400.00 n.a.
Enovation Controls (ENOV) Morgan Stanley/ UBS Securities $100.00 n.a.
GC Aesthetics plc (GCAA) BofA Merrill Lynch/ Deutsche Bank Securities/ Cowen and Company 5.35 $13.00 $15.00 $74.90 1-Star
Intercorp Financial Services (IFSP) BofA Merrill Lynch/ Credit Suisse $400.00 n.a.
rEVO Biologics (RBIO) Piper Jaffray/ Guggenheim Securities 3.60 $13.00 $15.00 $50.40 1-Star
New Terms
Cerecor (CERC) Maxim Group LLC 4.23 $6.00 $7.00 $27.50 n.a.
First Data   (FDC) Citigroup/ Morgan Stanley/ BofA Merrill Lynch/ KKR/ Barclays/ Credit Suisse/ Deutsche Bank Securities/ Goldman Sachs/ HSBC/ Mizuho Securities/ PNC Capital Markets/ SunTrust Robinson Humphrey/ Wells Fargo Securities $100.00 n.a.
Mapi – Pharma Ltd. (MAPI) Maxim Group/ LLC MLV & Co. $57.50 n.a.
Nabriva Therapeutics AG (NBRV) Leerink Partners/ RBC Capital Markets 6.00 $15.00 $17.00 $96.00 2-Stars
Oasmia Pharmaceutical AB   (OASM) Ladenburg Thalmann $5.25 $8.25 $23.00 N/C
PAVmed (PAVMU) (u) Benchmark/ BANQ $23.00 n.a.
Penumbra  (PEN) J.P. Morgan/ BofA Merrill Lynch 3.80 $25.00 $28.00 $100.70 2-Stars
REGENXBIO Inc.  (RGNX) Morgan Stanley/ BofA Merrill Lynch/ Piper Jaffray 5.56 $17.00 $19.00 $100.00 2-Stars
N/C = No Call – Stock has been listed on the NASDAQ Stockholm since  2010 and on the Frankfurt Stock Exchange since  2011.
IPOs Priced Lead Shares Amount Offer Close %
Week of Aug. 31, 2015 Manager(s) Offered Raised Price 9/4/15 Change
Double Eagle Acquisition (EAGLU) (u) Deutsche Bank Securities/ BofA Merrill Lynch 40.00 $400.00 $10.00 $10.05 0.50%
Pace Holdings  (PACEU) (u) Deutsche Bank Securities/ Citigroup 40.00 $400.00 $10.00 $10.11 1.10%
u (unit offering)